Sarin, Navin <br/><br/>
Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest.  [electronic resource] 

 -  PloS one  2017 
 - e0181081 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0181081  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>A549 Cells<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Ataxia Telangiectasia Mutated Proteins--genetics<br/>Blotting, Western<br/>Carcinoma, Non-Small-Cell Lung--genetics<br/>Carrier Proteins--genetics<br/>Cisplatin--pharmacology<br/>Cyclin-Dependent Kinase Inhibitor p21--genetics<br/>DNA-Binding Proteins--genetics<br/>Drug Resistance, Neoplasm--drug effects<br/>G2 Phase Cell Cycle Checkpoints--drug effects<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Heat-Shock Proteins--genetics<br/>Humans<br/>Lung Neoplasms--genetics<br/>Proto-Oncogene Proteins c-mdm2--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Tumor Suppressor Protein p53--genetics